Clarksburg, MD—BrightFocus Foundation, through its National Glaucoma Research program, today issued a request for proposals for promising research in the field of glaucoma.
New grants are available for research that begins in 2020, with an application deadline of November 8, 2019. BrightFocus grants cover a wide range of investigator-initiated topics in basic, clinical and translational research. Typically these awards are made to early-stage investigators, or to more established investigators who are proposing particularly innovative research.
BrightFocus funding has blazed new trails of discovery, including breakthroughs that have led to two Nobel Prizes. Its glaucoma program is currently supporting 32 scientific projects worldwide. “We encourage scientists from around the globe to bring us their most creative, most innovative ideas,” says Diane Bovenkamp, PhD, BrightFocus Vice President for Scientific Affairs.
Application deadline: November 08, 2019, 5:00 PM EST
Amount: $100,000 per year
Award Duration: 2 years maximum (total value $200,000)
BrightFocus Foundation is a premier source of private research funding to defeat Alzheimer’s, macular degeneration, and glaucoma. The organization currently manages a global portfolio of over 200 grants, a $40 million investment in the bold science that will find the cures for diseases of mind and sight. We share the latest research findings and best practices to empower families impacted by
Preeti Subramanian, PhD, Director of Scientific Programs, Vision Science
Manager of Communications and Marketing
The information provided in this section is a public service of BrightFocus Foundation, and should not in any way substitute for the advice of a qualified healthcare professional, and is not intended to constitute medical advice. Although we take efforts to keep the medical information on our website updated, we cannot guarantee that the information on our website reflects the most up-to-date research. Please consult your physician for personalized medical advice; all medications and supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical product or therapy.
Some of the content in this section is adapted from other sources, which are clearly identified within each individual item of information.